Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

0.94
Delayed Data
As of 3:59pm ET
 +0.03 / +3.30%
Today’s Change
0.71
Today|||52-Week Range
2.89
-23.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues201.0K405.0K1.3M8.3M
 
 
 
 
 
Cost of Goods Sold258.0K411.0K1.0M5.5M
 
 
 
 
 
Depreciation And Amortization274.0K298.0K299.0K748.0K
 
 
 
 
 
 
Operating ExpensesGross Income-331.0K-304.0K17.0K2.0M
 
 
 
 
 
General Expenses7.9M13.0M14.6M17.9M
 
 
 
 
 
Research And Development1.2M1.7M2.2M3.0M
 
 
 
 
 
Total Operating Expenses8.5M13.8M15.9M24.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.3M-13.3M-14.5M-15.9M
 
 
 
 
 
Extraordinary Credit24.0K55.0K79.0K--
 
 
 
 
Extraordinary Charge-635.0K0.000.00-1.1M
 
 
 
Interest Expense On Debt1.9M0.00--48.0K
 
 
 
Other Expenses9.0K-24.0K-157.0K-397.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.7M-13.2M-14.5M-17.3M
 
 
 
 
 
Income Taxes0.000.00-15.0K-19.0K
 
 
 
Discontinued Operations239.0K273.0K0.000.00
 
 
 
Net Income-10.5M-12.9M-14.5M-17.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.4M9.6M11.2M15.1M
 
 
 
 
 
Shares To Calculate EPS Diluted4.4M9.6M11.2M15.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.35-$1.34-$1.29-$1.15
 
 
 
 
 
EPS Diluted-$2.35-$1.34-$1.29-$1.15